GOLDEN STAPH Alert on new highly pathogenic strain - Nature | Health Blog
"Man vs. MRSA" is the title of the new alert, launched in the journal Nature autisme by Dr. Daum, founder of the Centre for Research on MRSA from the University of Chicago, the risk of epidemic related to this new strain of origin and non-hospital community-resistant Staphylococcus aureus (MRSA). For decades, Robert Daum studied and already warned about the dangers of this strain. He adds, with this article, the findings of the recent study published February 1 in the Journal of Infectious Diseases informing the scientific community about the highly pathogenic nature of the MRSA "that catch" outside the hospital . The urgency to develop a vaccine very quickly.
In 1995, Dr. Robert Daum of the Children's Hospital of Chicago autisme had the support of infections who had received a score of children in the emergency department. 3 children were suffering from pneumonia rapidly evolving, a 4th had a huge abscess in a muscle. In a 5th child, the bacteria had infected the bones of a foot. Infections showed themselves resistant to many antibiotics, including methicillin. The culprit MRSA. Yet none of the children was passed by hospitalization during the preceding months.
At the time Dr. Daum had published in 1998 an article in the Journal of the American Medical autisme Association (JAMA) reporting these cases, alerting the danger of this new strain of MRSA, community autisme and non-hospital-and its special features in comparison with hospital strains.
Again, Dr. Daum has sounded alarm in the journal Nature on the risk of epidemics. While over the last 10 years, MRSA has become resistant to antibiotics even last resort, while laboratories are reluctant to develop new drugs to fight bacteria whose resistance is changing too fast to recoup their costs. Laboratories, Nabi Biopharmaceuticals, GlaxoSmithKline and Merck have done well but attempts were not successful. Robert Daum, meanwhile, is working with his team to a vaccination strategy that stimulates T cells, which play an important role in the secondary immune response, sustained strategy or discussed by many scientists.
The epidemic is growing: Cases of MRSA "Community" are increasing, according to reports from the Centers for Disease Control and Prevention (CDC), 4 children had died in 2011 of this type of infection, outbreaks are identified in the prisons, in certain sports teams, in an unusually high number of patients arriving by emergency services. Doctors declare unexpected serious infections such necrotizing pneumonia caused by this strain acquired in community.
According to one estimate, MRSA acquired in community would be responsible for more than 14 million infections of skin and soft tissue autisme causing hospitalizations or emergency room visits, approximately 100,000 serious blood infections and more than 15,000 deaths each year .
MRSA bacteria is community-acquired resistant to almost all antibiotics. Staphylococcus aureus autisme lives on the skin or in the nose of a third of us, most of the time without causing disease, which means that much of us already has antibodies. However, these antibodies do not mean "protection", one in four people who have MRSA develop another type of infection.
Immunization track based on pro-inflammatory protein called interleukin-17, produced autisme by a different branch of the immune system than that manuf
"Man vs. MRSA" is the title of the new alert, launched in the journal Nature autisme by Dr. Daum, founder of the Centre for Research on MRSA from the University of Chicago, the risk of epidemic related to this new strain of origin and non-hospital community-resistant Staphylococcus aureus (MRSA). For decades, Robert Daum studied and already warned about the dangers of this strain. He adds, with this article, the findings of the recent study published February 1 in the Journal of Infectious Diseases informing the scientific community about the highly pathogenic nature of the MRSA "that catch" outside the hospital . The urgency to develop a vaccine very quickly.
In 1995, Dr. Robert Daum of the Children's Hospital of Chicago autisme had the support of infections who had received a score of children in the emergency department. 3 children were suffering from pneumonia rapidly evolving, a 4th had a huge abscess in a muscle. In a 5th child, the bacteria had infected the bones of a foot. Infections showed themselves resistant to many antibiotics, including methicillin. The culprit MRSA. Yet none of the children was passed by hospitalization during the preceding months.
At the time Dr. Daum had published in 1998 an article in the Journal of the American Medical autisme Association (JAMA) reporting these cases, alerting the danger of this new strain of MRSA, community autisme and non-hospital-and its special features in comparison with hospital strains.
Again, Dr. Daum has sounded alarm in the journal Nature on the risk of epidemics. While over the last 10 years, MRSA has become resistant to antibiotics even last resort, while laboratories are reluctant to develop new drugs to fight bacteria whose resistance is changing too fast to recoup their costs. Laboratories, Nabi Biopharmaceuticals, GlaxoSmithKline and Merck have done well but attempts were not successful. Robert Daum, meanwhile, is working with his team to a vaccination strategy that stimulates T cells, which play an important role in the secondary immune response, sustained strategy or discussed by many scientists.
The epidemic is growing: Cases of MRSA "Community" are increasing, according to reports from the Centers for Disease Control and Prevention (CDC), 4 children had died in 2011 of this type of infection, outbreaks are identified in the prisons, in certain sports teams, in an unusually high number of patients arriving by emergency services. Doctors declare unexpected serious infections such necrotizing pneumonia caused by this strain acquired in community.
According to one estimate, MRSA acquired in community would be responsible for more than 14 million infections of skin and soft tissue autisme causing hospitalizations or emergency room visits, approximately 100,000 serious blood infections and more than 15,000 deaths each year .
MRSA bacteria is community-acquired resistant to almost all antibiotics. Staphylococcus aureus autisme lives on the skin or in the nose of a third of us, most of the time without causing disease, which means that much of us already has antibodies. However, these antibodies do not mean "protection", one in four people who have MRSA develop another type of infection.
Immunization track based on pro-inflammatory protein called interleukin-17, produced autisme by a different branch of the immune system than that manuf
No comments:
Post a Comment